Published in Ment Illn on January 30, 2012
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
Management of treatment resistance in schizophrenia. Biol Psychiatry (2001) 2.20
Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull (2008) 1.93
Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophr Bull (2008) 1.70
Past and present progress in the pharmacologic treatment of schizophrenia. J Clin Psychiatry (2010) 1.65
Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine: a meta-analysis. J Clin Psychopharmacol (2007) 1.63
A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr Med Chem (2004) 1.35
Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr Bull (1992) 1.17
Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull (1988) 1.11
Polypharmacy in schizophrenia. Curr Opin Psychiatry (2010) 1.07
Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies. Acta Psychiatr Scand (2009) 0.92
Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophr Res (2005) 1.73
Incidence of cancer and statin usage--record linkage study. Int J Cancer (2010) 1.51
Statin usage and all-cause and disease-specific mortality in a nationwide study. Pharmacoepidemiol Drug Saf (2011) 1.50
Cluster-randomized controlled trial of reducing seclusion and restraint in secured care of men with schizophrenia. Psychiatr Serv (2013) 1.48
Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am J Hum Genet (2012) 1.47
Pharmacotherapy of methamphetamine addiction: an update. Subst Abus (2008) 1.36
Dopamine and alcoholism: neurobiological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.29
No mental health without physical health. Lancet (2011) 1.22
Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study. Clin Epidemiol (2013) 1.09
Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects: a whole-hemisphere autoradiography study. Am J Psychiatry (2002) 1.05
Seasonal variation in specific methods of suicide: a national register study of 20,234 Finnish people. J Affect Disord (2002) 1.02
Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Hum Brain Mapp (2003) 1.00
Total serum cholesterol level, violent criminal offences, suicidal behavior, mortality and the appearance of conduct disorder in Finnish male criminal offenders with antisocial personality disorder. Eur Arch Psychiatry Clin Neurosci (2002) 1.00
Abnormal hippocampal shape in offenders with psychopathy. Hum Brain Mapp (2010) 0.99
Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Neuroimage (2003) 0.98
The consequences of Conduct Disorder for males who develop schizophrenia: associations with criminality, aggressive behavior, substance use, and psychiatric services. Schizophr Res (2005) 0.98
Prefrontal volumes in habitually violent subjects with antisocial personality disorder and type 2 alcoholism. Psychiatry Res (2002) 0.95
Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Res (2002) 0.95
Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study. Int Clin Psychopharmacol (2014) 0.94
Cortex and amygdala morphology in psychopathy. Psychiatry Res (2011) 0.94
Premorbid personality factors in schizophrenia and bipolar disorder: results from a large cohort study of male conscripts. J Abnorm Psychol (2009) 0.94
Incidence of cancer and antidepressant medication: record linkage study. Int J Cancer (2010) 0.92
Is occupation relevant in suicide? J Affect Disord (2002) 0.92
A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia. Biol Psychiatry (2002) 0.91
Effects of MAOA-genotype, alcohol consumption, and aging on violent behavior. Alcohol Clin Exp Res (2008) 0.91
Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia. Pharmacoepidemiol Drug Saf (2008) 0.91
The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients. Biol Psychiatry (2003) 0.90
Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial. Schizophr Res (2009) 0.90
Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction (2013) 0.89
Gender differences in brain serotonin transporter availability in panic disorder. J Psychopharmacol (2010) 0.89
Description of long-term polypharmacy among schizophrenia outpatients. Soc Psychiatry Psychiatr Epidemiol (2012) 0.89
Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the Kuopio ischaemic heart disease risk factor study. PLoS One (2007) 0.88
MAOA alters the effects of heavy drinking and childhood physical abuse on risk for severe impulsive acts of violence among alcoholic violent offenders. Alcohol Clin Exp Res (2010) 0.88
Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort. Pharmacoepidemiol Drug Saf (2012) 0.88
High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort. Eur Neuropsychopharmacol (2014) 0.87
Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970. Neurosci Lett (2004) 0.87
Impaired temporal lobe processing of preattentive auditory discrimination in schizophrenia. Schizophr Bull (2002) 0.86
Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res (2004) 0.86
Atypical nucleus accumbens morphology in psychopathy: another limbic piece in the puzzle. Int J Law Psychiatry (2013) 0.86
Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging. Psychiatry Res (2007) 0.85
Midbrain binding of [123I]nor-beta-CIT in atypical depression. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.85
Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland. J Clin Psychopharmacol (2014) 0.85
Cardiac repolarization and striatal dopamine transporter function are interrelated. Nucl Med Commun (2009) 0.84
Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.84
Correlation between the SERT binding densities in hypothalamus and amygdala in Cloninger type 1 and 2 alcoholics. Alcohol Alcohol (2007) 0.84
Cortical dopamine D2 receptors in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Synapse (2004) 0.84
Concomitant use of acetylcholine esterase inhibitors and urinary antispasmodics among Finnish community-dwelling persons with Alzheimer disease. J Clin Psychopharmacol (2014) 0.83
Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: the HUUTI study. BMC Public Health (2013) 0.83
Lower serotonin transporter binding in caudate in alcoholics. Synapse (2006) 0.82
The place of observational studies in assessing the effectiveness of depot antipsychotics. Schizophr Res (2011) 0.82
Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease. Int Clin Psychopharmacol (2015) 0.82
Recidivistic offending and mortality in alcoholic violent offenders: a prospective follow-up study. Psychiatry Res (2009) 0.82
Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression. Psychiatry Clin Neurosci (2010) 0.81
From prescriptions to drug use periods - things to notice. BMC Res Notes (2014) 0.81
Use of statistical techniques in studies of suicide seasonality, 1970 to 1997. Suicide Life Threat Behav (2002) 0.81
More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.81
Sociodemographic characteristics and drug abuse patterns of treatment-seeking illicit drug abusers in Finland, 1997-2008: the Huuti study. J Addict Dis (2012) 0.81
Midbrain dopamine D2/3 receptor binding in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2006) 0.81
Amygdala serotonin transporters in alcoholics measured by whole hemisphere autoradiography. Synapse (2007) 0.81
Group psychoeducation for long-term offender patients with schizophrenia: an exploratory randomised controlled trial. Crim Behav Ment Health (2010) 0.81
Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort. Eur J Clin Pharmacol (2009) 0.80
mGluR1/5 receptor densities in the brains of alcoholic subjects: a whole-hemisphere autoradiography study. Psychiatry Res (2012) 0.80
Psychopathy, PCL-R, and MAOA genotype as predictors of violent reconvictions. Psychiatry Res (2010) 0.80
Comorbid personality disorders and substance use disorders of mentally ill homicide offenders: a structured clinical study on dual and triple diagnoses. Schizophr Bull (2004) 0.80
Examining the effectiveness of antipsychotic medication in first-episode psychosis. J Psychopharmacol (2012) 0.80
Elevated midbrain serotonin transporter availability in mixed mania: a case report. BMC Psychiatry (2004) 0.80
Metacognitive group training for forensic and dangerous non-forensic patients with schizophrenia: a randomised controlled feasibility trial. Crim Behav Ment Health (2014) 0.80
Autoradiographic characterization of alpha(2C)-adrenoceptors in the human striatum. Synapse (2008) 0.80
123I-beta-CIT binding and recovery from depression. A six-month follow-up study. Eur Arch Psychiatry Clin Neurosci (2004) 0.79
Visualization of the cortical dopamine transporter in type 1 and 2 alcoholics with human whole hemisphere autoradiography. Eur Neuropsychopharmacol (2006) 0.79
Different effect of age on dopamine transporters in the dorsal and ventral striatum of controls and alcoholics. Synapse (2003) 0.79
Mortality among clients seeking treatment for buprenorphine abuse in Finland. Drug Alcohol Depend (2013) 0.79
Striatal dopamine D1 receptors in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Brain Res (2005) 0.78
Energy substrate metabolism among habitually violent alcoholic offenders having antisocial personality disorder. Psychiatry Res (2007) 0.78
Endogenous cannabinoids in post-mortem brains of Cloninger type 1 and 2 alcoholics. Eur Neuropsychopharmacol (2010) 0.78
Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study. Int J Neuropsychopharmacol (2009) 0.78
Association of serotonin transporter promoter regulatory region polymorphism and cerebral activity to visual presentation of food. Clin Physiol Funct Imaging (2008) 0.78
Twelve-year trend in treatment seeking for buprenorphine abuse in Finland. Drug Alcohol Depend (2012) 0.78
MRI volumetry of the vermis and the cerebellar hemispheres in men with schizophrenia. Psychiatry Res (2004) 0.78
Low non-oxidative glucose metabolism and violent offending: an 8-year prospective follow-up study. Psychiatry Res (2009) 0.78
Seasonal variations in [3H]citalopram platelet binding between healthy controls and violent offenders in Finland. Hum Psychopharmacol (2005) 0.77
The substance use among forensic psychiatric patients. Am J Drug Alcohol Abuse (2012) 0.77
Decreased GABA(A) benzodiazepine binding site densities in postmortem brains of Cloninger type 1 and 2 alcoholics. Alcohol (2013) 0.77
Treatment improves serotonin transporter binding and reduces binge eating. Psychopharmacology (Berl) (2003) 0.77
The intergenerational cycle of criminality--association with psychopathy. J Forensic Sci (2009) 0.77
Extrapyramidal side-effects and dopamine D(2/3) receptor binding in substantia nigra. Nord J Psychiatry (2010) 0.77
Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine. Psychiatry Clin Neurosci (2009) 0.77
Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase. Hum Psychopharmacol (2011) 0.77
AMPA receptors in post-mortem brains of Cloninger type 1 and 2 alcoholics: a whole-hemisphere autoradiography study. Psychiatry Res (2013) 0.77
Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study. Neurosci Lett (2008) 0.77
Transmission of violent offending and crime across three generations. Soc Psychiatry Psychiatr Epidemiol (2007) 0.77
SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci (2004) 0.77
Temporal cortex dopamine D2/3 receptor binding in major depression. Psychiatry Clin Neurosci (2008) 0.76
Nucleus accumbens serotonin transporters in alcoholics measured by whole-hemisphere autoradiography. Alcohol (2007) 0.76
More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial. Hum Psychopharmacol (2010) 0.76
Dopamine transporter binding in females with panic disorder may vary with clinical status. J Psychiatr Res (2009) 0.76
Influence of serotonin transporter gene polymorphism (5-HTTLPR polymorphism) on the relation between brain 5-HT transporter binding and heart rate corrected cardiac repolarization interval. PLoS One (2013) 0.76
Cortical dopamine D(1) receptors in type 1 and type 2 alcoholics measured with human whole hemisphere autoradiography. Psychiatry Res (2007) 0.76
An outcome of psychodynamic psychotherapy: a case study of the change in serotonin transporter binding and the activation of the dream screen. Am J Psychother (2005) 0.76
5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography. Alcohol Alcohol (2008) 0.76